Harbin Medisan Pharmaceutical CO.,LTD.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Harbin Sanlian Pharmaceutical Co., Ltd. (hereinafter referred to as "Harbin Sanlian") is a high-tech enterprise specializing in the research and development, production, and sales of chemical drug formulations. The company was founded in 1996. In 2001, freeze-dried powder injections, small capacity injections, and large capacity injections passed the national GMP certification in one go. The production capacity of the enterprise has rapidly increased, and the economic benefits have rapidly improved. Since 2011, the company has been pursuing prosperity and development based on group operation, and has officially established Harbin Sanlian Pharmaceutical Research Institute. It completed its shareholding transformation in 2013 and was successfully listed on the Shenzhen Stock Exchange on September 22, 2017. The company adopts a modern management philosophy and adheres to the principle of honest operation. For many years, it has been awarded the national "AAA Credit Enterprise in Enterprise Credit Evaluation" and the 2016 Top 100 Comprehensive Strength of China's Pharmaceutical Research and Development. It has been recognized as the National Enterprise Technology Center and National Postdoctoral Research Station, and has been included in the "National Thousand Household Group Headquarters Enterprise" by the State Administration of Taxation. In the future, the company will continue to adhere to the corporate tenet of "Harbin Sanlian, serving you", deeply implement the transformation and upgrading development strategy, adhere to the overall tone of seeking progress while maintaining stability, and adhere to the new development concept. Taking differentiated innovation as the driving force, exploring enterprise resources, and collaborating with manufacturing platform advantages to achieve win-win cooperation; Implement the "dual wheel drive" strategy of industry and capital, accelerate transformation and upgrading, and promote high-quality development; Our vision is to create a century old foundation, serve human health with professional technology, and make contributions to society. |
| Headquarter | Harbin |
| Establish Date | 6/21/1996 |
| Listed Code | 002900.SZ |
| Listed Date | 9/22/2017 |
| Chairman | Qin Jianfei. |
| CEO | Qin Jianfei. |
| Website | www.medisan.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
